Results 71 to 80 of about 10,619,315 (293)
A Nonrepudiable Threshold Multi-Proxy Multi-Signature Scheme with Shared Verification
, 2012 [[abstract]]In this paper, we shall propose a threshold multi-proxy multi-signature scheme with shared verification. In the scheme allows the group of original signers to delegate the signing capability to the designated group of proxy signers ...
黃明祥;Hwang, Min-Shiang
core
Threshold Signatures, Multisignatures and Blind Signatures Based on the Gap-Diffie-Hellman-Group Signature Scheme [PDF]
, 2002 We propose a robust proactive threshold signature scheme, a multisignature scheme and a blind signature scheme which work in any Gap Diffie-Hellman (GDH) group (where the Computational Diffie-Hellman problem is hard but the Decisional Diffie-Hellman problem is easy).
openaire +1 more source
FEBS Open Bio, EarlyView.Human ABCE1 cannot functionally replace its yeast ortholog. Yeast–human chimera analysis identified NBD1 as a major interspecies barrier. Genetic screening yielded hABCE1 revertants that rescue yeast viability but fail to suppress aberrant translation reinitiation in the 3′ UTR.
Eriko Nakata +3 more
wiley +1 more source
A Novel Efficient (t,n) Threshold Proxy Signature Scheme
, 2009 [[abstract]]All previously proposed threshold proxy signature schemes have been based on discrete logarithms required for a protocol to generate and verify a shared secret among the proxy group. Therefore, it is necessary for the proxy signers to perform
Huang, H. F. ; Chang, C. C.
core
Transcribed-ultra conserved region expression is associated with outcome in high-risk neuroblastoma
BMC Cancer, 2009 Background Neuroblastoma is the most common, pediatric, extra-cranial, malignant solid tumor. Despite multimodal therapeutic protocols, outcome for children with a high-risk clinical phenotype remains poor, with long-term survival still less than 40 ...
Garaventa Alberto +8 more
doaj +1 more source
IGF2 knockout reduces but does not abolish osteosarcoma growth in vitro and in vivo
FEBS Open Bio, EarlyView.To test whether endogenous IGF2 promotes osteosarcoma growth, IGF2 was knocked out in Saos2 cells via CRISPR‐Cas9. KO cells showed reduced proliferation in vitro, and knockout xenografts in mice reached only ~25% of wild‐type tumor volume. Insulin‐like growth factor 2 (IGF2) is implicated in osteosarcoma, but direct functional evidence of its role is ...
Shun Yao, Marco Archetti
wiley +1 more source
Frontiers in ImmunologyIntroductionThis study investigated pyroptosis- and immunity-related long non-coding RNAs (lncRNAs) to identify promising therapeutic targets for breast cancer (BC), and constructed lncRNA signatures to determine the prognosis and immunotherapy responses
Dedi Kong +3 more
doaj +1 more source
FEBS Open Bio, EarlyView.Life‐science educators from 14 countries redesigned their own course materials with generative AI in a three‐session, pedagogy‐first FEBS Education and Training Academy workshop built on PICRAT. Among 12 matched respondents, four more reported high confidence in each of five practical domains, and 10 of 13 reported implementing at least one idea ...
Zvonimir Mlinarić, Ali Burak Özkaya
wiley +1 more source
Cryptanalysis of Nonrepudiable Threshold Proxy Signature Schemes with Known Signers
, 2010 Sun's nonrepudiation threshold proxy signature scheme is not secure against the collusion attack. In order to guard against the attack, Hwang et al. proposed another threshold proxy signature scheme.
Hwang, Shin-jia; Chen, Chiu-chin
core
CybersecurityExisting threshold Pointcheval–Sanders (PS) signature schemes largely assume equal-weight participants and therefore cannot directly express heterogeneous signing authority in semi-trusted multi-organization settings.
Yanshuo Zhang +5 more
doaj +1 more source